Identifying M1 Macrophage-Related Genes Through a Co-expression Network to Construct a Four-Gene Risk-Scoring Model for Predicting Thyroid Cancer Prognosis-Reference-Cited by-同舟云学术

Identifying M1 Macrophage-Related Genes Through a Co-expression Network to Construct a Four-Gene Risk-Scoring Model for Predicting Thyroid Cancer Prognosis

Published:2020-10-29 Issue: Volume:11 Page:
ISSN:1664-8021
Container-title:Frontiers in Genetics
language:
Short-container-title:Front. Genet.

Author:

Zhuang Gaojian,Zeng Yu,Tang Qun,He Qian,Luo Guoqing

Publisher

Frontiers Media SA

Subject

Genetics (clinical),Genetics,Molecular Medicine

Reference40 articles.

1. The human solute carrier family 11 member 1 protein (SLC11A1): linking infections, autoimmunity and cancer?;Awomoyi;FEMS Immunol. Med. Microbiol.,2007

2. Salmonella meningitis associated with monocyte infiltration in mice.;Bauler;Am. J. Pathol.,2017

3. Prediction of high anti-angiogenic activity peptides in silico using a generalized linear model and feature selection.;Blanco;Sci. Rep.,2018

4. Multi-omics signatures and translational potential to improve thyroid cancer patient outcome.;Boufraqech;Cancers,2019

5. Susceptibility to leishmaniasis is affected by host SLC11A1 gene polymorphisms: a systematic review and meta-analysis.;Braliou;Parasitol. Res.,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a metabolism-linked genomic signature for prognosis and immunotherapeutic efficiency in metastatic skin cutaneous melanoma;Medicine;2024-06-07

2. Predictive Panel for Immunotherapy in Low-Grade Glioma;World Neurosurgery;2024-03

3. Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma;Frontiers in Immunology;2023-07-03

4. Immune gene signatures as prognostic criteria for cancer patients;Therapeutic Advances in Medical Oncology;2023-01

5. SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer;Frontiers in Pharmacology;2022-11-09